Sinerginiai verslo projektai, UAB - financials and debts

Company age: 12 y. 1 mo.

Update

Sinerginiai verslo projektai - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 3,692,384 3,395,607 1,226,173 1,857,440 5,707,494 15,552,211 23,557,708 21,095,381
Profit before tax 102,571 -64,566 30,882 31,558 -20,614 635,641 350,885 658,462
Net profit 89,635 -64,566 29,338 28,286 -20,614 528,483 293,256 548,492
Equity 87,320 22,753 52,092 80,378 59,764 588,247 881,602 1,414,701
Liabilities 769,689 665,077 685,594 971,639 2,981,137 2,636,613 1,583,090 411,605
Non-current assets 26,607 100,454 110,250 102,550 157,914 48,256 50,710 105,352
Current assets 816,284 581,158 627,346 948,889 2,882,880 3,171,968 2,413,596 1,715,814
Total assets 842,891 681,612 737,596 1,051,439 3,040,794 3,220,224 2,464,306 1,821,166
Taxes paid
STI taxes - - - - - - 112,050 19,284
Social insurance contributions - - - - - 26,049 27,184 35,463
Financial indicators
Revenue change y/y +61.2% -8.0% -63.9% +51.5% +207.3% +172.5% +51.5% -10.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 10.6% -9.5% 4.0% 2.7% -0.7% 16.4% 11.9% 30.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 102.7% -283.8% 56.3% 35.2% -34.5% 89.8% 33.3% 38.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 2.4% -1.9% 2.4% 1.5% -0.4% 3.4% 1.2% 2.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 2.8% -1.9% 2.5% 1.7% -0.4% 4.1% 1.5% 3.1%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 8.8 29.2 13.2 12.1 49.9 4.5 1.8 0.3
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 738,477 565,935 188,642 285,760 1,070,162 3,332,593 5,889,427 4,364,592

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Sinerginiai verslo projektai - Social security debts

From To Debt, €
2025-05-16 2025-06-02 0.23
2025-04-24 2025-04-29 0.23
2025-01-16 2025-01-20 173.19

Sinerginiai verslo projektai - VMI tax arrears

From To Overdue, €
2026-08-14 2026-08-19 6.35
2026-08-13 2026-08-13 7.47
2025-04-28 2025-04-28 118.65

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Sinerginiai verslo projektai, UAB (code 303377027) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, revenue amounted to €21.10M, down 10.4% from 2024, but still above the 2023 level of €15.55M, which indicates strong two-year growth of 35.6%. Net profit in 2025 reached €548.5K, compared with €293.3K in 2024 and €528.5K in 2023, while the profit margin improved to 2.6% from 1.2% a year earlier. The company’s balance sheet remained lean, with total assets of €1.82M, equity of €1.41M and liabilities of €411.6K at the end of 2025. The equity ratio stood at 77.7% and debt-to-equity at 0.29, reflecting a conservative capital structure. Return on equity was 38.8% and return on assets 30.1%, supported by an asset turnover of 11.58x. Revenue per employee was €5.27M and profit per employee €137.1K, indicating high productivity.